Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance.

Wu FH, Yuan Y, Li D, Liao SJ, Yan B, Wei JJ, Zhou YH, Zhu JH, Zhang GM, Feng ZH.

Cancer Lett. 2012 Apr 28;317(2):157-64. doi: 10.1016/j.canlet.2011.11.020. Epub 2011 Nov 22.

PMID:
22115967
2.

Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.

Gong W, Wang ZY, Chen GX, Liu YQ, Gu XY, Liu WW.

Oncol Rep. 2013 Sep;30(3):1249-56. doi: 10.3892/or.2013.2595. Epub 2013 Jul 5.

PMID:
23836405
3.

Targeting nuclear factor-κB suppresses the negative effect of toll-like receptor 4 signaling on antimetastasis therapy based on targeting αvβ3.

Zhu JH, Yuan Y, Li D, Liao SJ, Zhou YH, Wang Q, Shu Y, Yan B, Wei JJ, Sun R, Zhang GM, Feng ZH.

Cancer Sci. 2012 Jul;103(7):1319-26. doi: 10.1111/j.1349-7006.2012.02299.x. Epub 2012 May 15.

4.

Lipopolysaccharide initiates a bypass feedback loop of epidermal growth factor receptor signaling by HPS70-induced COX-2 in H22 hepatocarcinoma cells.

Gong W, Zhang JL, Yan XJ, Zhou Q, Wang ZY, Yi TN.

Oncol Rep. 2011 Dec;26(6):1505-11. doi: 10.3892/or.2011.1426. Epub 2011 Aug 19.

PMID:
21874253
5.

[Tyroservatide inhibits the growth of human hepatocarcinoma in nude mice].

Jia J, Lu R, Fu Z, Qiu S, Shi LX, Jian X, Liu JY, Li HQ, Che XC, Yao Z.

Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):426-8. Chinese.

PMID:
17152487
6.

Activation of hepatocytes by extracellular heat shock protein 72.

Galloway E, Shin T, Huber N, Eismann T, Kuboki S, Schuster R, Blanchard J, Wong HR, Lentsch AB.

Am J Physiol Cell Physiol. 2008 Aug;295(2):C514-20. doi: 10.1152/ajpcell.00032.2008. Epub 2008 May 28.

8.

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.

9.

Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation.

Sun Q, Zheng Y, Liu Q, Cao X.

Int Immunopharmacol. 2008 Dec 20;8(13-14):1854-8. doi: 10.1016/j.intimp.2008.08.009. Epub 2008 Sep 21.

PMID:
18789402
10.

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.

Jang GY, Jeon JH, Cho SY, Shin DM, Kim CW, Jeong EM, Bae HC, Kim TW, Lee SH, Choi Y, Lee DS, Park SC, Kim IG.

Oncogene. 2010 Jan 21;29(3):356-67. doi: 10.1038/onc.2009.342. Epub 2009 Oct 19.

PMID:
19838207
11.

The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.

Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E.

Carcinogenesis. 2011 Nov;32(11):1634-40. doi: 10.1093/carcin/bgr198. Epub 2011 Sep 1.

12.

[Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].

Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY.

Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1666-70. Chinese.

PMID:
16854316
13.

[Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].

Ding L, Chen XP, Zhang ZW, Wang H, Cao B, Wang ZH, Li CL.

Zhonghua Wai Ke Za Zhi. 2005 Oct 1;43(19):1248-53. Chinese.

PMID:
16271222
14.

Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.

Zhuang PY, Zhang JB, Zhang W, Zhu XD, Liang Y, Xu HX, Xiong YQ, Kong LQ, Wang L, Wu WZ, Tang ZY, Qin LX, Sun HC.

J Cancer Res Clin Oncol. 2010 Dec;136(12):1891-900. doi: 10.1007/s00432-010-0848-1. Epub 2010 Mar 6.

PMID:
20213095
15.

The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro.

Klink M, Nowak M, Kielbik M, Bednarska K, Blus E, Szpakowski M, Szyllo K, Sulowska Z.

Cell Stress Chaperones. 2012 Nov;17(6):661-74. doi: 10.1007/s12192-012-0338-2. Epub 2012 Apr 24.

16.

[Enhancing effect of matrine on the tumor-inhibition by TIM2 gene-modified hepatocarcinoma H22 cells in mice].

Ma LD, Zhang Y, Wen SH, He YJ, Liu XS, Kang GF, Jiang JK.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):255-8. Chinese.

PMID:
18788626
17.

Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y.

Gastroenterology. 2008 Sep;135(3):956-68. doi: 10.1053/j.gastro.2008.05.025. Epub 2008 May 7.

PMID:
18555021
18.

Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.

Xu YZ, Zheng RL, Zhou Y, Peng F, Lin HJ, Bu Q, Mao YQ, Yu LT, Yang L, Yang SY, Zhao YL.

Cancer Lett. 2011 Dec 26;313(1):44-53. doi: 10.1016/j.canlet.2011.08.025. Epub 2011 Sep 8.

PMID:
21944661
19.

Toll-like receptor 4 signaling promotes tumor growth.

Lee CH, Wu CL, Shiau AL.

J Immunother. 2010 Jan;33(1):73-82. doi: 10.1097/CJI.0b013e3181b7a0a4.

PMID:
19952954
20.

Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury.

Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, Roos M, Kirschning C, Heemann U, Lutz J.

Pediatr Nephrol. 2010 May;25(5):853-60. doi: 10.1007/s00467-009-1422-4. Epub 2010 Feb 4.

PMID:
20130923
Items per page

Supplemental Content

Write to the Help Desk